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Nosocomial bloodstream infections (BSI) are associated with
high morbidity and mortality resulting in increased health-
care costs.1,2 BSI rates in Latin America range from 11.3 to 23
cases per 1000 catheter-days and are higher than those in the
USA and Europe.3—5 This study characterized the trends in the
agents causing BSI in intensive care units (ICUs), and the risk
factors associated with death, at a large university hospital in
Brazil.
All cases of BSI were identified by surveillance using
Centers for Disease Control and Prevention criteria.6 Crude
mortality and mortality that occurred during the14 days from
first blood isolation were evaluated. The Chi-square test for
linear trends was used to evaluate the distribution of the
most common agents. A logistic regression model was devel-
oped to identify factors associated with mortality.
Over 5 years, 1121 episodes of BSI were detected in 1004
patients. The incidence of BSI did not change significantly,
ranging from 11.2 to 10.2 episodes per 1000 catheter-days
( p = 0.61). Forty-nine percent of the episodes were caused
by Gram-negative rods, 45% by Gram-positive cocci, and 6%
by fungi. The incidence of Gram-negative rods increased
( p = 0.04), Gram-positive cocci decreased ( p = 0.01), and
fungi remained stable ( p = 0.20). The mean time from admis-
sion into the ICU to the development of BSI was 16.9 days,Table 1 Main pathogens causing bloodstream infections (BSI) and
at the Hospital das Clı´nicas of the University of Sa˜o Paulo, Brazila
Pathogen N
14
Pseudomonas aeruginosa 55
Candida non-albicans 20
Candida albicans 15
Klebsiella pneumoniae 41
Acinetobacter baumannii 97
Staphylococcus aureus 11
Enterococcus faecalis 26
Coagulase-negative staphylococci 41
Enterobacter spp 16
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doi:10.1016/j.ijid.2008.03.011ranging from 6 (coagulase-negative staphylococci) to 31
days (Proteus mirabilis). The most frequent underlying dis-
eases were neurological (13.1%), followed by cardiovascular
(10.4%) and gastrointestinal diseases (10%). Central venous
catheters were present in 93% of patients.
Staphylococcus aureus (24.4%) was the most common
agent, followed by Acinetobacter baumannii (19.2%), coa-
gulase-negative staphylococci (11.3%), Pseudomonas aerugi-
nosa (8.2%), Klebsiella pneumoniae (7.1%), Enterococcus
faecalis (6.8%), and Candida spp (5.6%). The resistance to
imipenem increased among Acinetobacter baumannii from
12% to 41% ( p = 0.0002).
The overall mortality rate was 38%. The mortality related
to the agents is shown in Table 1. Age over 60 years was the
only risk factor independently associated with death and
trauma; burns and neurological disease were associated with
lower mortality risk.
Our results show a Gram-negative predominance, with a
significant increase in the incidence of A. baumannii and K.
pneumoniae over time. Acinetobacter spp has been particu-
larly problematic in Latin American hospitals, with a high
frequency of isolates and high rates of resistance.7,8 Data
from other developing countries have also shown the impor-
tance of Gram-negative bacteria as agents of BSI.9,10
Our BSI rates remained stable over the study period and
are lower than other reports from Latin America, however
they are higher than those found in American and European
hospitals.their 14 day-mortality and crude mortality over a 5-year period
umber of deaths/total BSI (%)
-day mortality Crude mortality
/104 (53%) 81/104 (78%)
/40 (50%) 32/40 (80%)
/33 (45%) 24/33 (73%)
/100 (41%) 57/100 (57%)
/246 (39%) 163/246 (66%)
0/312 (35%) 191/312 (61%)
/88 (30%) 57/88 (65%)
/142 (29%) 72/142 (51%)
/81 (20%) 45/81 (56%)
04 patients.
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